Source link : https://newshealth.biz/health-news/diabetes-patients-on-semaglutide-had-fewer-fractures-study-finds/
CHICAGO — The GLP-1 receptor agonist semaglutide (Ozempic, Wegovy) was associated with a 15% lower risk for fractures in adults with type 2 diabetes, a review of medical records found. In a matched analysis involving more than 35,000 patients, fractures occurred in 4.54% of semaglutide users over roughly 3.5 years of follow-up compared with 5.97% […]
The post Diabetes Patients on Semaglutide Had Fewer Fractures, Study Finds first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-15 17:57:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8